Validation
Product validation
Title 21: Food and Drugs
PART 820—QUALITY SYSTEM REGULATION
Subpart C—Design Controls
§820.30 Design controls.
(a) General. (1) Each manufacturer of any class III or class II device, and the class I devices listed in paragraph (a)(2) of this section, shall establish and maintain procedures to control the design of the device in order to ensure that specified design requirements are met.
(g) Design validation. Each manufacturer shall establish and maintain procedures for validating the device design. Design validation shall be performed under defined operating conditions on initial production units, lots, or batches, or their equivalents. Design validation shall ensure that devices conform to defined user needs and intended uses and shall include testing of production units under actual or simulated use conditions. Design validation shall include software validation and risk analysis, where appropriate. The results of the design validation, including identification of the design, method(s), the date, and the individual(s) performing the validation, shall be documented in the DHF.
Process validation
Title 21: Food and Drugs
PART 820—QUALITY SYSTEM
REGULATION
Subpart G—Production and
Process Controls
(a) Where the results of a process cannot be fully verified by subsequent inspection and test, the process shall be validated with a high degree of assurance and approved according to established procedures. The validation activities and results, including the date and signature of the individual(s) approving the validation and where appropriate the major equipment validated, shall be documented.
(b) Each manufacturer shall establish and maintain procedures for monitoring and control of process parameters for validated processes to ensure that the specified requirements continue to be met.
(1) Each manufacturer shall ensure that validated processes are performed by qualified individual(s).
(2) For validated processes, the monitoring and control methods and data, the date performed, and, where appropriate, the individual(s) performing the process or the major equipment used shall be documented.
(c) When changes or process deviations occur, the manufacturer shall review and evaluate the process and perform revalidation where appropriate. These activities shall be documented.
Contact us for effective Validation of:
- Medical Device Safety & Efficacy
- Production Processes
- Computer System Validation (CSV)
- Enterprise Resource Planning (ERP)
- Software & Hardware
Quality Management Systems - Process Validation Guidance
International Medical Device Regulators Forum (IMDRF)
www.imdrf.org
www.imdrf.org/documents/documents.asp
https://www.hekmat-consulting.de/
Interim Management & effective Consulting
Regulatory Affairs & Quality Management, Class III Medical Devices & Combination products
30 years of effective Strategic & Operative expertise in Clinical & Regulatory Affairs plus Quality Management for Medical Devices industry. Market Access, within the medical fields of Arterial implants, Cardiology, open Heart & Vascular Surgery, Ophthalmology, Neuro-stimulation, Orthopedics, Dental Care, Modern Wound Care, Regional Anesthesia, Minimal Invasive Surgery, Navigated Robotic Surgery, OCT, CT & NMR digital Imaging (3D), and in vitro Diagnostics.
Technical Documentation (DHF, DMR, DHR), STED, including Analysis & Evaluation of Product Function & Safety, Biocompatibility, Packaging, Labeling (UDI), Sterilization, Laboratory results, Software & Hardware.
Compliance to applicable Standards (ISO, IEC, EN, MIL).
Certifications acc. current EN ISO 13485 Quality Management Systems,
GMP, GCP, GLP, GDP,
Manufacturing Process Verification, Validation (IQ, OQ, PQ).
Product & Production-process Risk Management from Design to market (Risk Analysis & Risk Control), including Artificial Intelligence, & Additive Manufacturing.
Clinical Evaluation, Organization of global multicenter Clinical Studies.
Audits of Production Processes & Suppliers.
Medical Device Reporting to Competent Authorities (e.g. BfArM, FDA).
Corrective And Preventive Action (CAPA) / Non-Conformity (NC) / corrective Project.
On site Support in Notified Body audits, and FDA inspections.
Effective management leading to a multitude of marketing approvals in the EU, Americas (FDA), & Asia, including Reimbursement schemes.
Dr. Hekmat CONSULTING
https://www.hekmat-consulting.de/
VAT-ID / USt-ID: DE295239280
Tübingen, Germany (Stuttgart area)
DUNS number 313240073
Email:
hekmat(at)hekmat-consulting.de
secure email: A.Hekmat(at)protonmail.ch
Mobile: +49 170 8530715
Skype: anuschirawan.hekmat
Druckversion 